4506

COM:SUMITOMO-PHARMA

Sumitomo Pharma Co., Ltd.

  • Stock

Last Close

609.00

25/11 00:54

Market Cap

162.09B

Beta: -

Volume Today

820K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
34.71B
-
33.76B
2.75%
39.56B
17.20%
47.22B
19.36%
53.45B
13.20%
48.63B
9.02%
35.92B
26.14%
36.83B
2.54%
40.60B
10.24%
-96.71B
338.21%
-314.97B
225.67%
depreciation and amortization
26.78B
-
19.23B
28.20%
20.27B
5.40%
18.62B
8.13%
12.89B
30.78%
13.98B
8.45%
17.36B
24.25%
22.67B
30.57%
38.35B
69.14%
41.26B
7.60%
37.77B
8.48%
deferred income tax
stock based compensation
change in working capital
-6.93B
-
12.99B
287.46%
12.21B
6.02%
6.72B
44.94%
15.52B
130.88%
-13.82B
189.07%
-20.85B
50.85%
66.33B
418.08%
-33.73B
150.86%
34.88B
203.39%
-95.85B
374.81%
accounts receivables
-3.63B
-
-16.37B
351.07%
185M
101.13%
-6.10B
3,395.68%
51.22B
940.05%
23.39B
54.33%
inventory
4.92B
-
-790M
116.06%
-3.03B
283.04%
-9.27B
206.21%
-4.38B
52.71%
-3.21B
26.81%
-14.35B
347.58%
-10.04B
30.06%
5.36B
153.35%
4.56B
14.86%
-11.79B
358.66%
accounts payables
-10.87B
-
15.24B
240.22%
-320M
102.10%
-28.67B
8,859.06%
5.32B
118.55%
5.64B
6.15%
other working capital
-11.85B
-
13.78B
216.31%
15.23B
10.55%
15.99B
4.94%
19.90B
24.48%
3.88B
80.49%
-5.37B
238.17%
76.50B
1,525.93%
-4.32B
105.65%
-26.22B
506.48%
-113.09B
331.33%
other non cash items
-4.61B
-
-35.72B
674.52%
-22.62B
36.68%
-50.93B
125.17%
11.56B
122.71%
-69M
100.60%
13.70B
19,950.72%
9.77B
28.66%
-13.98B
243.02%
32.51B
332.61%
189.45B
482.74%
net cash provided by operating activities
49.94B
-
30.25B
39.43%
49.41B
63.35%
21.62B
56.24%
93.42B
332.02%
48.71B
47.86%
46.13B
5.30%
135.60B
193.97%
31.24B
76.96%
11.94B
61.79%
-241.89B
2,126.41%
investments in property plant and equipment
-21.56B
-
-12.37B
42.63%
-9.74B
21.24%
-13.46B
38.18%
-12.35B
8.21%
-12.91B
4.53%
-13.35B
3.38%
-10.81B
19.06%
-13.49B
24.88%
-12.74B
5.57%
-15.73B
23.45%
acquisitions net
-2.83B
-
-729M
74.19%
-1.26B
73.53%
-84.35B
6,567.83%
9.42B
111.17%
1.69B
82.03%
-205.77B
12,254.40%
15.92B
107.74%
-3.70B
123.24%
30.17B
915.24%
9.04B
70.04%
purchases of investments
-51.60B
-
-36.02B
30.18%
-297M
99.18%
-356M
19.87%
-6.23B
1,648.88%
-2.78B
55.38%
-112.49B
3,949.46%
-9.37B
91.67%
-25.91B
176.59%
-6.25B
75.88%
-4.77B
23.61%
sales maturities of investments
50.00B
-
50.82B
1.64%
24.88B
51.04%
8.94B
64.09%
31M
99.65%
-1.69B
5,561.29%
1.62B
195.87%
8.14B
401.60%
19.47B
139.18%
10.07B
48.29%
34.50B
242.66%
other investing activites
-234M
-
21.75B
9,392.74%
2.31B
89.39%
29.50B
1,178.67%
-7.40B
125.08%
-19.36B
161.69%
17.31B
189.44%
4.98B
71.22%
5.35B
7.37%
31.17B
482.58%
10B
67.92%
net cash used for investing activites
-26.21B
-
23.45B
189.47%
15.89B
32.24%
-59.73B
475.96%
-16.52B
72.34%
-35.05B
112.12%
-312.68B
792.13%
8.88B
102.84%
-18.28B
305.95%
52.42B
386.79%
33.04B
36.98%
debt repayment
-20B
-
-10.35B
48.26%
-36.53B
253.01%
-22B
39.77%
-19.40B
11.82%
-12.96B
33.20%
-19.62B
51.41%
-2.96B
84.92%
-4.96B
67.57%
-20.06B
304.44%
-84B
318.74%
common stock issued
common stock repurchased
dividends paid
-7.15B
-
-7.15B
0%
-7.15B
0%
-7.15B
0.01%
-7.94B
11.09%
-11.12B
40.01%
-13.11B
17.84%
-11.12B
15.15%
-11.13B
0.05%
-11.13B
0.01%
-2.79B
74.90%
other financing activites
-12M
-
1.77B
14,891.67%
1.08B
39.38%
39.03B
3,527.51%
-2.27B
105.81%
-4.56B
101.37%
263.81B
5,881.50%
-43.13B
116.35%
-5.34B
87.62%
-115.63B
2,065.39%
659M
100.57%
net cash used provided by financing activities
-27.16B
-
-15.72B
42.11%
-42.60B
170.94%
9.88B
123.19%
-29.61B
399.67%
-28.64B
3.26%
231.08B
906.71%
-57.22B
124.76%
-21.43B
62.55%
-146.82B
585.23%
77.85B
153.03%
effect of forex changes on cash
7.95B
-
10.70B
34.63%
-8.22B
176.85%
-1.75B
78.75%
-5.12B
192.62%
4.50B
188.05%
-113M
102.51%
4.73B
4,284.96%
17.75B
275.36%
24.09B
35.71%
15.44B
35.91%
net change in cash
2.48B
-
48.88B
1,866.80%
12.78B
73.85%
-29.97B
334.50%
42.17B
240.70%
-10.48B
124.85%
-35.59B
239.61%
91.99B
358.49%
9.29B
89.91%
-59.51B
740.81%
-114.43B
92.30%
cash at beginning of period
71.43B
-
73.92B
3.48%
122.79B
66.12%
135.57B
10.41%
105.60B
22.11%
147.78B
39.93%
137.30B
7.09%
101.71B
25.92%
193.70B
90.45%
202.98B
4.79%
143.48B
29.32%
cash at end of period
73.92B
-
122.79B
66.12%
135.57B
10.41%
105.60B
22.11%
147.78B
39.93%
137.30B
7.09%
101.71B
25.92%
193.70B
90.45%
202.98B
4.79%
143.48B
29.32%
29.05B
79.76%
operating cash flow
49.94B
-
30.25B
39.43%
49.41B
63.35%
21.62B
56.24%
93.42B
332.02%
48.71B
47.86%
46.13B
5.30%
135.60B
193.97%
31.24B
76.96%
11.94B
61.79%
-241.89B
2,126.41%
capital expenditure
-21.56B
-
-12.37B
42.63%
-9.74B
21.24%
-13.46B
38.18%
-12.35B
8.21%
-12.91B
4.53%
-13.35B
3.38%
-10.81B
19.06%
-13.49B
24.88%
-12.74B
5.57%
-15.73B
23.45%
free cash flow
28.39B
-
17.89B
37.00%
39.67B
121.83%
8.16B
79.42%
81.07B
892.85%
35.80B
55.84%
32.78B
8.44%
124.80B
280.74%
17.75B
85.78%
-805M
104.54%
-257.62B
31,902.86%

All numbers in (except ratios and percentages)